Balchem Co. (NASDAQ:BCPC) Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. lifted its stake in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 129.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 98,853 shares of the basic materials company's stock after purchasing an additional 55,822 shares during the quarter. Victory Capital Management Inc. owned 0.30% of Balchem worth $17,398,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Envestnet Portfolio Solutions Inc. lifted its holdings in Balchem by 1.5% in the 2nd quarter. Envestnet Portfolio Solutions Inc. now owns 3,926 shares of the basic materials company's stock worth $604,000 after buying an additional 59 shares during the period. Inspire Investing LLC raised its stake in Balchem by 2.7% during the third quarter. Inspire Investing LLC now owns 2,348 shares of the basic materials company's stock valued at $413,000 after buying an additional 62 shares during the last quarter. Hsbc Holdings PLC raised its stake in Balchem by 1.5% during the second quarter. Hsbc Holdings PLC now owns 4,915 shares of the basic materials company's stock valued at $757,000 after buying an additional 75 shares during the last quarter. Atomi Financial Group Inc. increased its holdings in shares of Balchem by 6.1% in the 3rd quarter. Atomi Financial Group Inc. now owns 1,674 shares of the basic materials company's stock worth $295,000 after purchasing an additional 96 shares in the last quarter. Finally, Xponance Inc. increased its holdings in shares of Balchem by 5.2% in the 2nd quarter. Xponance Inc. now owns 2,046 shares of the basic materials company's stock worth $315,000 after purchasing an additional 102 shares in the last quarter. 87.91% of the stock is currently owned by institutional investors.

Balchem Trading Up 0.3 %

Shares of BCPC traded up $0.50 during mid-day trading on Wednesday, reaching $178.03. 82,172 shares of the company's stock traded hands, compared to its average volume of 109,937. The stock has a market cap of $5.79 billion, a P/E ratio of 47.86, a P/E/G ratio of 5.31 and a beta of 0.65. The stock's 50-day moving average is $173.39 and its two-hundred day moving average is $166.24. Balchem Co. has a 12 month low of $120.76 and a 12 month high of $186.03. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. StockNews.com raised Balchem from a "hold" rating to a "buy" rating in a report on Monday, October 28th. HC Wainwright boosted their price objective on Balchem from $185.00 to $190.00 and gave the company a "buy" rating in a research report on Monday, November 4th.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.